Seaport Global Acquisition II (SGII) 10-Q 13 Nov 23 2023 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2023	Nov. 10, 2023
Document and Entity Information
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2023
Entity Registrant Name	Seaport Global Acquisition II Corp.
Entity Incorporation, State or Country Code	DE
Entity File Number	001-41075
Entity Tax Identification Number	87-1326052
Entity Address, Address Line One	360 Madison Avenue, 23rd Floor
Entity Address, City or Town	New York
Entity Address State Or Province	NY
Entity Address, Postal Zip Code	10017
City Area Code	212
Local Phone Number	616-7700
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Entity Common Stock, Shares Outstanding		6,982,479
Entity Central Index Key	0001869824
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Amendment Flag	false
Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant
Document and Entity Information
Title of 12(b) Security	Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant
Trading Symbol	SGIIU
Security Exchange Name	NASDAQ
Class A common stock
Document and Entity Information
Title of 12(b) Security	Class A common stock, par value $0.0001 per share
Trading Symbol	SGII
Security Exchange Name	NASDAQ
Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50
Document and Entity Information
Title of 12(b) Security	Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
Trading Symbol	SGIIW
Security Exchange Name	NASDAQ

CONDENSED BALANCE SHEETS

CONDENSED BALANCE SHEETS - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Current assets
Cash	$ 31,494	$ 292,717
Prepaid expenses	181,139	61,863
Income tax receivable		113,624
Total current assets	212,633	468,204
Cash and securities held in Trust Account	36,392,519	147,639,566
Total Assets	36,605,152	148,107,770
Current liabilities:
Accounts payable and accrued expenses	2,153,357	827,669
Franchise tax payable	30,000	$ 179,951
Convertible promissory note - related party	$ 1,200,000
Notes Payable, Current, Related Party, Type [Extensible Enumeration]	Related Party [Member]	Related Party [Member]
Excise tax payable	$ 1,131,343
Current taxes payable	108,767
Total current liabilities	4,623,467	$ 1,007,620
Income taxes payable		132,872
Deferred underwriting fee payable	5,031,250	5,031,250
Warrant liability	828,737	162,181
Forward purchase agreement liability	2,212,335
Total liabilities	12,695,789	6,333,923
Commitments and contingencies
Stockholders' Deficit:
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Accumulated deficit	(12,404,748)	(5,238,270)
Total stockholders' deficit	(12,404,389)	(5,237,911)
Total Liabilities and Stockholders' Deficit	36,605,152	148,107,770
Class A common stock subject to possible redemption
Current liabilities:
Class A common stock subject to possible redemption, $0.0001 par value; 3,388,729 shares and 14,375,000 shares issued and outstanding at redemption value at September 30, 2023 and December 31, 2022 respectively	36,313,752	147,011,758
Class A common stock non-redeemable
Stockholders' Deficit:
Common stock	$ 359	0
Class B common stock
Stockholders' Deficit:
Common stock		$ 359

CONDENSED BALANCE SHEETS (Paren

CONDENSED BALANCE SHEETS (Parenthetical) - $ / shares	Sep. 30, 2023	Dec. 31, 2022
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	1,000,000	1,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Class A common stock
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	100,000,000	100,000,000
Common stock, shares issued (in shares)	0	0
Common stock, shares outstanding (in shares)	0	0
Class A common stock subject to possible redemption
Class A common stock subject to possible redemption, par value (in dollars per share)	$ 0.0001	$ 0.0001
Class A common stock subject to possible redemption, issued (in shares)	3,388,729	14,375,000
Class A common stock subject to possible redemption, outstanding (in shares)	3,388,729	14,375,000
Class A common stock non-redeemable
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	100,000,000	100,000,000
Common stock, shares issued (in shares)	3,593,750	0
Common stock, shares outstanding (in shares)	3,593,750	0
Class B common stock
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	10,000,000	10,000,000
Common stock, shares issued (in shares)	0	3,593,750
Common stock, shares outstanding (in shares)	0	3,593,750

CONDENSED STATEMENTS OF OPERATI

CONDENSED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
General and administrative expense	$ 914,000	$ 337,271	$ 2,325,429	$ 1,631,493
Franchise tax expense	50,000	49,913	150,000	148,148
Loss from operations	(964,000)	(387,184)	(2,475,429)	(1,779,641)
Other income (loss):
Gain on marketable securities held in Trust Account	529,408	693,891	2,182,510	890,956
Change in fair value of warrant liability	461,605	1,636,842	(666,556)	5,093,141
Initial measurement of forward purchase agreement liability			(2,016,000)
Change in fair value of forward purchase agreement liability	(322,335)		(196,335)
Total other income, net	668,678	2,330,733	(696,381)	5,984,097
Income (loss) before provision for income taxes	(295,322)	1,943,549	(3,171,810)	4,204,456
Provision for income taxes	100,675	145,333	427,003	152,157
Net income (loss)	(395,997)	1,798,216	(3,598,813)	4,052,299
Class A redeemable common stock
Other income (loss):
Net income allocable	$ (204,505)	$ 1,438,573	$ (2,213,599)	$ 3,421,839
Basic and diluted net income per share
Weighted average shares outstanding, basic	3,837,956	14,375,000	5,742,884	14,375,000
Weighted average shares outstanding, diluted	3,837,956	14,375,000	5,742,884	14,375,000
Basic net income per common share	$ (0.05)	$ 0.10	$ (0.39)	$ 0.23
Diluted net income per common share	$ (0.05)	$ 0.10	$ (0.39)	$ 0.23
Class A non-redeemable common stock
Other income (loss):
Net income allocable	$ (191,492)	$ 359,643	$ (1,385,214)	$ 810,460
Basic and diluted net income per share
Weighted average shares outstanding, basic	3,593,750	3,593,750	3,593,750	3,593,750
Weighted average shares outstanding, diluted	3,593,750	3,593,750	3,593,750	3,593,750
Basic net income per common share	$ (0.05)	$ 0.10	$ (0.39)	$ 0.23
Diluted net income per common share	$ (0.05)	$ 0.10	$ (0.39)	$ 0.23

CONDENSED STATEMENTS OF CHANGES

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)	Class A common stock subject to possible redemption Common Stock	Class A common stock subject to possible redemption	Class A common stock non-redeemable Common Stock	Class B common stock Common Stock	Accumulated Deficit	Total
Balance at the beginning at Dec. 31, 2021	$ 145,906,254
Balance at the beginning (in shares) at Dec. 31, 2021	14,375,000
Balance at the end at Jun. 30, 2022	$ 145,906,254
Balance at the end (in shares) at Jun. 30, 2022	14,375,000
Balance at the beginning at Dec. 31, 2021	$ 145,906,254
Balance at the beginning (in shares) at Dec. 31, 2021	14,375,000
Balance at the beginning at Dec. 31, 2021				$ 359	$ (10,894,548)	$ (10,894,189)
Balance at the beginning (in shares) at Dec. 31, 2021				3,593,750
Increase (Decrease) in Stockholders' Equity
Net income (loss)					2,254,083	2,254,083
Balance at the end at Jun. 30, 2022	$ 145,906,254
Balance at the end (in shares) at Jun. 30, 2022	14,375,000
Balance at the end at Jun. 30, 2022				$ 359	(8,640,465)	(8,640,106)
Balance at the end (in shares) at Jun. 30, 2022				3,593,750
Balance at the beginning at Dec. 31, 2021	$ 145,906,254
Balance at the beginning (in shares) at Dec. 31, 2021	14,375,000
Balance at the end at Sep. 30, 2022	$ 146,492,458
Balance at the end (in shares) at Sep. 30, 2022	14,375,000
Balance at the beginning at Dec. 31, 2021	$ 145,906,254
Balance at the beginning (in shares) at Dec. 31, 2021	14,375,000
Balance at the beginning at Dec. 31, 2021				$ 359	(10,894,548)	(10,894,189)
Balance at the beginning (in shares) at Dec. 31, 2021				3,593,750
Increase (Decrease) in Stockholders' Equity
Net income (loss)						4,052,299
Balance at the end at Sep. 30, 2022	$ 146,492,458
Balance at the end (in shares) at Sep. 30, 2022	14,375,000
Balance at the end at Sep. 30, 2022				$ 359	(7,428,453)	(7,428,094)
Balance at the end (in shares) at Sep. 30, 2022				3,593,750
Balance at the beginning at Jun. 30, 2022	$ 145,906,254
Balance at the beginning (in shares) at Jun. 30, 2022	14,375,000
Balance at the end at Sep. 30, 2022	$ 146,492,458
Balance at the end (in shares) at Sep. 30, 2022	14,375,000
Balance at the beginning at Jun. 30, 2022	$ 145,906,254
Balance at the beginning (in shares) at Jun. 30, 2022	14,375,000
Balance at the beginning at Jun. 30, 2022				$ 359	(8,640,465)	(8,640,106)
Balance at the beginning (in shares) at Jun. 30, 2022				3,593,750
Increase (Decrease) in Stockholders' Equity
Net income (loss)					1,798,216	1,798,216
Remeasurement of Class A ordinary shares to redemption value	$ 586,204				(586,204)	(586,204)
Balance at the end at Sep. 30, 2022	$ 146,492,458
Balance at the end (in shares) at Sep. 30, 2022	14,375,000
Balance at the end at Sep. 30, 2022				$ 359	(7,428,453)	(7,428,094)
Balance at the end (in shares) at Sep. 30, 2022				3,593,750
Balance at the beginning at Dec. 31, 2022	$ 147,011,758	$ 147,011,758
Balance at the beginning (in shares) at Dec. 31, 2022	14,375,000	14,375,000
Balance at the end at Jun. 30, 2023	$ 44,709,514
Balance at the end (in shares) at Jun. 30, 2023	4,249,748
Balance at the beginning at Dec. 31, 2022	$ 147,011,758	$ 147,011,758
Balance at the beginning (in shares) at Dec. 31, 2022	14,375,000	14,375,000
Balance at the beginning at Dec. 31, 2022				$ 359	(5,238,270)	(5,237,911)
Balance at the beginning (in shares) at Dec. 31, 2022				3,593,750
Increase (Decrease) in Stockholders' Equity
Net income (loss)					(3,202,816)	(3,202,816)
Redemption of Class A ordinary shares	$ (104,028,741)
Redemption of Class A ordinary shares (in share)	(10,125,252)
Remeasurement of Class A ordinary shares to redemption value	$ 1,726,497				(1,726,497)	(1,726,497)
Conversion of Class B common shares to Class A common shares			$ 359	$ (359)
Conversion of Class B common shares to Class A common shares (in shares)			3,593,750	(3,593,750)
Excise tax on redeemed shares					(1,040,287)	(1,040,287)
Balance at the end at Jun. 30, 2023	$ 44,709,514
Balance at the end (in shares) at Jun. 30, 2023	4,249,748
Balance at the end at Jun. 30, 2023			$ 359		(11,207,870)	(11,207,511)
Balance at the end (in shares) at Jun. 30, 2023			3,593,750
Balance at the beginning at Dec. 31, 2022	$ 147,011,758	$ 147,011,758
Balance at the beginning (in shares) at Dec. 31, 2022	14,375,000	14,375,000
Balance at the end at Sep. 30, 2023	$ 36,313,752	$ 36,313,752
Balance at the end (in shares) at Sep. 30, 2023	3,388,729	3,388,729
Balance at the beginning at Dec. 31, 2022	$ 147,011,758	$ 147,011,758
Balance at the beginning (in shares) at Dec. 31, 2022	14,375,000	14,375,000
Balance at the beginning at Dec. 31, 2022				$ 359	(5,238,270)	(5,237,911)
Balance at the beginning (in shares) at Dec. 31, 2022				3,593,750
Increase (Decrease) in Stockholders' Equity
Net income (loss)						(3,598,813)
Balance at the end at Sep. 30, 2023	$ 36,313,752	$ 36,313,752
Balance at the end (in shares) at Sep. 30, 2023	3,388,729	3,388,729
Balance at the end at Sep. 30, 2023			$ 359		(12,404,748)	(12,404,389)
Balance at the end (in shares) at Sep. 30, 2023			3,593,750
Balance at the beginning at Jun. 30, 2023	$ 44,709,514
Balance at the beginning (in shares) at Jun. 30, 2023	4,249,748
Balance at the end at Sep. 30, 2023	$ 36,313,752	$ 36,313,752
Balance at the end (in shares) at Sep. 30, 2023	3,388,729	3,388,729
Balance at the beginning at Jun. 30, 2023	$ 44,709,514
Balance at the beginning (in shares) at Jun. 30, 2023	4,249,748
Balance at the beginning at Jun. 30, 2023			$ 359		(11,207,870)	(11,207,511)
Balance at the beginning (in shares) at Jun. 30, 2023			3,593,750
Increase (Decrease) in Stockholders' Equity
Net income (loss)					(395,997)	(395,997)
Redemption	$ (9,105,587)
Redemption (in shares)	(861,019)
Remeasurement of Class A ordinary shares to redemption value	$ 709,825				(709,825)	(709,825)
Excise tax on redeemed shares					(91,056)	(91,056)
Balance at the end at Sep. 30, 2023	$ 36,313,752	$ 36,313,752
Balance at the end (in shares) at Sep. 30, 2023	3,388,729	3,388,729
Balance at the end at Sep. 30, 2023			$ 359		$ (12,404,748)	$ (12,404,389)
Balance at the end (in shares) at Sep. 30, 2023			3,593,750

CONDENSED STATEMENT OF CASH FLO

CONDENSED STATEMENT OF CASH FLOW - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net income (loss)	$ (3,598,813)	$ 4,052,299
Adjustments to reconcile net income (loss)to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account	(2,182,510)	(5,093,141)
Initial measurement of forward purchase agreement liability	2,016,000
Change in fair value of forward purchase agreement liability	196,335
Change in fair value of warrant liability	666,556	(890,956)
Changes in operating assets and liabilities:
Prepaid expenses	(119,276)	428,136
Accounts payable and accrued expenses	1,325,688	682,729
Franchise tax payable	(149,951)	107,348
Income tax payable	89,519	138,068
Net cash used in operating activities	(1,756,452)	(575,517)
Cash flows from investing activities:
Payment for extension into Trust Account	(356,094)
Proceeds from withdrawal of Trust Account	651,323	40,747
Cash withdrawn from Trust Account in connection with redemption	113,134,328
Net cash provided by investing activities	113,429,557	40,747
Cash flows from financing activities:
Proceeds from promissory note - related party	1,200,000
Redemption of ordinary shares	(113,134,328)
Net cash used in financing activities	(111,934,328)
Net change in cash	(261,223)	(534,770)
Cash, beginning of period	292,717	954,598
Cash, end of the period	31,494	419,828
Supplemental cash flow information:
Cash paid for income taxes	337,426	14,000
Supplemental disclosure of non-cash investing and financing activities:
Remeasurement adjustment on redeemable common stock	2,436,322	$ 586,204
Excise tax payable on redeemed shares	1,131,343
Forward purchase agreement liability	$ 2,212,335

Organization and Business Opera

Organization and Business Operation	9 Months Ended
	Sep. 30, 2023
Organization and Business Operation
Organization and Business Operation	Note 1 — Organization and Business Operation Seaport Global Acquisition II Corp. (the “Company”) is a blank check company incorporated in Delaware on June 21, 2021. The Company was formed for the purpose of effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses (the “Business Combination”). The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of September 30, 2023, the Company had not yet commenced any operations. All activity for the period from January 1, 2023 through September 30, 2023, and the prior year comparable period, relates to the Company’s formation, initial public offering (the “Initial Public Offering”), which is described below, and the Company’s search for a Target for its Business Combination. On June 1, 2023, the Company entered into an Agreement and Plan of Merger (“ Merger Agreement Merger Sub ABM The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end. The registration statement for the Company’s Initial Public Offering was declared effective on November 17, 2021. On November 19, 2021, the Company consummated the Initial Public Offering of 14,375,000 units (the “Units” and, with respect to the shares of Class A common stock included in the Units sold, the “Public Shares”), which includes the full exercise by the underwriter of the overallotment option to purchase an additional 1,875,000 Units at $10.00 per Unit, generating gross proceeds of $143,750,000, which is described in Note 3. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 7,531,250 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant in a private placement to Seaport Global SPAC II, LLC (the “Sponsor”) generating gross proceeds of $7,531,250, which is described in Note 4. Following the closing of the Initial Public Offering on November 19, 2021 an amount of $145,906,250 ($10.15 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”) and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less, or in money market funds investing solely in United States government treasury obligations and meeting the conditions of paragraphs (d)(1), (d)(2), (d)(3) and (d)(4) of Rule 2a-7 under the Investment Company Act (or any successor rule), until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the funds in the Trust Account to the Company’s stockholders, as described below. The Company’s management has broad discretion with respect to the specific application of the remaining net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the remaining net proceeds are intended to be applied generally toward consummating a Business Combination. NASDAQ rules provide that the Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (less any deferred underwriting commissions and taxes payable on interest earned on the Trust Account) at the time of the signing a definitive agreement to enter a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination. The Company will provide its holders of the outstanding Public Shares (the “public stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. In connection with a proposed Business Combination, the Company may seek stockholder approval of a Business Combination at a meeting called for such purpose at which stockholders may seek to redeem their shares, regardless of whether they vote for or against a Business Combination. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 either immediately prior to or upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination. If the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s Amended and Restated Certificate of Incorporation provides that, a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from seeking redemption rights with respect to 20% or more of the Public Shares without the Company’s prior written consent. The public stockholders will be entitled to redeem their shares for a pro rata portion of the amount then in the Trust Account (initially $10.15 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed to stockholders who redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriter (as discussed in Note 7). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. If a stockholder vote is not required and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation, offer such redemption pursuant to the tender offer rules of the Securities and Exchange Commission (the “SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. The Company’s Sponsor has agreed (a) to vote its Founder Shares (as defined in Note 5), and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination, (b) not to propose an amendment to the Company’s Amended and Restated Certificate of Incorporation with respect to the Company’s pre-Business Combination activities prior to the consummation of a Business Combination unless the Company provides dissenting public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment; (c) not to redeem any shares (including the Founder Shares) and Private Placement Warrants (including underlying securities) into the right to receive cash from the Trust Account in connection with a stockholder vote to approve a Business Combination (or to sell any shares in a tender offer in connection with a Business Combination if the Company does not seek stockholder approval in connection therewith) or a vote to amend the provisions of the Amended and Restated Certificate of Incorporation relating to stockholders’ rights of pre-Business Combination activity and (d) that the Founder Shares and Private Placement Warrants (including underlying securities) shall not participate in any liquidating distributions upon winding up if a Business Combination is not consummated. However, the Sponsor will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares purchased during or after the Initial Public Offering if the Company fails to complete its Business Combination. The Company initially had until February 19, 2023 to complete a Business Combination (the “Combination Period”). On February 13, 2023, the Company held a special meeting of stockholders (the “Meeting”), during which the stockholders of the Company approved a proposal to extend the Combination Period to August 19, 2023 and allow holders of shares of Class B Common stock to convert such shares at any time at the election of the holder. On August 14, 2023, the Company held a special meeting of stockholders (the “Second Meeting”), during which the stockholders of the Company approved a proposal to extend the Combination Period by up to six one If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten In connection with the Meeting, the Company entered into Voting and Non-Redemption Agreements with certain stockholders of the Company holding an aggregate of 3,281,138 shares in exchange for their agreeing not to redeem shares of the Company’s common stock at the Meeting (collectively, the “Non-Redemption Agreements”). The Non-Redemption Agreements provide for the allocation of up to 820,284 shares of common stock of the Company held by the Sponsor. The stockholders party to the Non-Redemption Agreements only agreed to refrain from exercising redemption rights in connection with the Meeting and retain their redemption rights in connection with the approval of a Business Combination (or any future amendment to extend the period to complete a Business Combination). After the Meeting, an amendment to the Company’s amended and restated certificate of incorporation was filed with the Secretary of State of Delaware (as amended, the “A&R COI”), extending the Combination Period to August 19, 2023 and allowing holders of shares of the Company’s Class B Common Stock to convert such shares into shares of Class A Common Stock on a one-for-one basis at the election of the holder. In connection with the vote to approve the Extension Proposals, the holders of 10,125,252 public shares of common stock of the Company properly exercised their right to redeem their shares (and did not withdraw their redemption) for cash at a redemption price of approximately $10.27 per share, for an aggregate redemption amount of approximately $104 million. (the “Extension Redemptions”) On February 14, 2023, Seaport Global SPAC II, LLC, the Company’s sponsor (“Sponsor”) contributed to the Company for purposes of making a deposit into the Company’s trust account of an aggregate of 200,000 shares of Class B common stock (the “Trust Shares”) and $84,994.96 (or $0.02 per share of Class A Common Stock remaining after the Extension Redemptions (each a “Remaining Share”, and collectively, the “Remaining Shares”)) for the benefit of the public shares that were not redeemed by the public shareholders in connection with the Meeting. Following the foregoing contribution, the Sponsor owned 3,393,750 shares of Class B common stock. On February 16, 2023 the Sponsor converted the entirety of such shares into shares of Class A common stock, and including the additional 200,000 Class B Trust Shares which represent 46% of the outstanding shares of common stock of the Company. Effective on February 17, 2023, the Trust Shares were also converted to Class A Common Stock. Following the Extension Redemptions, including the Class B common stock, the Company had 7,843,498 shares of common stock outstanding, and the aggregate amount remaining in the Trust Account at the time was $43,662,709. In connection with the vote to approve the Second Extension, the holders of 861,019 public shares of common stock of the Company properly exercised their right to redeem their shares (and did not withdraw their redemption) for cash at a redemption price of approximately $10.58 per share, for an aggregate redemption amount of approximately $9.1 million (“Second Extension Redemptions”). Following the Second Extension Redemptions, the Company had 6,982,479 shares of common stock outstanding, and the aggregate amount remaining in the Trust Account at the time was approximately $35.8 million. In connection with the Second Extension, on August 16, 2023, we contributed an additional $135,549 of loan proceeds from our Sponsor to the Trust Account (“Extension Payment”), bringing the total in the Trust Account to approximately $36.0 million. Also on August 16, 2023, we amended our Trust Agreement with the Trustee. Since August 16, we have made two additional Extension Payments into the Trust Account. Pursuant to an amendment to the Merger Agreement, ABM was obligated to pay $0.015 per share of the Extension Payments in cash, or else it was obligated to contribute additional shares to our Sponsor at the closing. To date, ABM has not made any such payments in cash. The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.15 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the day of liquidation of the Trust Account, if less than $10.15 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriter of Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure its stockholders that the Sponsor would be able to satisfy those obligations. None of the Company’s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Liquidity and Going Concern As of September 30, 2023, the Company had cash outside the Trust Account of $31,494 available for working capital needs and a working capital deficit of approximately $(4.4) million. All remaining cash held in the Trust Account are generally unavailable for the Company’s use, prior to an initial business combination, and is restricted for use either in a Business Combination, pay the Company’s tax obligations, or to redeem common stock. Through September 30, 2023, the Company’s liquidity needs were satisfied through receipt of $25,000 from the sale of the founder shares and the remaining net proceeds from the IPO and the sale of Private Placement Units. In addition, on August 25, 2022 and November 25, 2022, the Company withdrew $40,747 and $374,062, respectively from the Trust Account to pay its income tax and Delaware franchise tax obligations. On February 23, 2023 and on August 17, 2023, the Company withdrew $582,139 and $69,184, respectively from the Trust Account to meet its income tax and Delaware franchise tax obligations. As of September 30, 2023, $284,388 of the amount held in the Trust Account was available to be withdrawn as described above, and as of December 31, 2022, $1,733,316 of the amount in the Trust Account were available to be withdrawn as described above. Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business Combination. Further, the Company has incurred and expects to continue to incur significant costs in pursuit of its acquisition plans. The possibility exists that within the coming 12 months the Company will need to raise additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors, or third parties. In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the initial stockholders or their affiliates may, but are not obligated to, loan us funds as may be required. If we complete a Business Combination, we would repay such loaned amounts. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from our Trust Account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into warrants identical to the Private Placement Warrants, at a price of $1.00 per warrant at the option of the lender. Accordingly, the Company may not be able to obtain additional financing if and when needed. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. These conditions raise substantial doubt about the Company’s ability to continue as a going concern through one year and one day from the date of issuance of these financial statements. These conditions raise substantial doubt about our ability to continue as a going concern. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern. In connection with our assessment of going concern considerations in accordance with the authoritative guidance in Financial Accounting Standard Board (“FASB”) Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that the mandatory liquidation and subsequent dissolution, should the we be unable to complete a business combination, raises substantial doubt about the our ability to continue as a going concern. We have until end of the Combination Period to consummate a Business Combination. It is uncertain that we will be able to consummate a Business Combination by this time. If a Business Combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate as of the end of the Combination Period. Risks and Uncertainties In March 2020, the World Health Organization declared the outbreak of a novel coronavirus (COVID-19) as a pandemic which continues to spread throughout the United States and the World. As of the date the financial statement was issued, there was considerable uncertainty around the expected duration of this pandemic. The Company has concluded that while it is reasonably possible that COVID-19 could have a negative effect on identifying a target company for a Business Combination, the specific impact is not readily determinable as of the date of this financial statement. In addition, our search for a target company may be impacted by the current hostilities between Russia and Ukraine, inflationary effects, and other similar events and the status of debt and equity markets. The financial statements do not include any adjustments that might result from the outcome of these uncertainties.

Significant Accounting Policies

Significant Accounting Policies	9 Months Ended
	Sep. 30, 2023
Significant Accounting Policies
Significant Accounting Policies	Note 2 — Significant Accounting Policies Basis of Presentation The accompanying condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X of the SEC. The results for the three and nine months ended September 30, 2023 are not necessarily indicative of the results to be expected for any future periods. In the opinion of the Company’s management, the accompanying condensed financial statements contain all adjustments necessary for a fair statement of the Company’s financial position as of September 30, 2023, its results of operations for the three- and nine-months ended September 30, 2023 and 2022 and its cash flows for the nine months ended September 30, 2023 and 2022. All such adjustments are of a normal and recurring nature. Emerging Growth Company Status The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of the financial statement in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Inflation Reduction Act of 2022 Except for franchise and income taxes, the proceeds placed in the trust account in connection with the Company’s initial public offering and any extension payments, as well as any interest earned thereon, shall not be used to pay for potential excise taxes or any other fees or taxes that may be levied on the Company pursuant to any current, pending or future rules or laws, including without limitation any excise tax due under the Inflation Reduction Act of 2022 on any redemptions or stock buybacks by the Company. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2023 or December 31, 2022. The Company had $31,494 of cash as of September 30, 2023 and $292,717 of cash as of December 31, 2022. Cash and Securities held in Trust Account At September 30, 2023, the assets held in the Trust Account were substantially held in U.S. Treasury Bills. As of September 30, 2023, the Trust Account held $36,391,529 in three-month U.S. Treasury Bills and $990 in cash. As of December 31, 2022, the Trust Account held $147,639,102 in three-month U.S. Treasury Bills and $464 in cash. During the period from January 1, 2023 and September 30, 2023, the Company withdrew $651,323 interest income from the Trust Account to pay its tax obligations and withdrew $40,747 during the period from January 1, 2022 to September 30, 2022. During the three months ended September 30, 2023, the Company withdrew $69,184 interest income from the Trust Account to pay its tax obligations and withdrew $40,747 during the comparable three month period in 2022. The Company classifies its United States Treasury securities as a trading security in accordance with FASB ASC Topic 320 “Investments - Debt and Equity Securities.” Per ASC 320-10-25 Trading securities are bought and held principally for the purpose of selling them in the near term and therefore held for only a short period of time. Trading generally reflects active and frequent buying and selling, and trading securities are generally used with the objective of generating profits on short-term differences in price. However, at acquisition the Company is not precluded from classifying as trading a security it plans to hold for a longer period. Interest income is recognized when earned and included in the “interest income” line item in the statements of operations. Derivative Financial Instruments Warrant and Forward Purchase Agreement Liabilities The Company accounts for warrants and forward purchase agreements as either equity-classified or liability-classified instruments based on an assessment of the warrant’s and forward purchase agreement’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants and forward purchase agreement are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants and forward purchase agreement meet all of the requirements for equity classification under ASC 815, including whether the warrants and forward purchase agreement are indexed to the Company’s own common shares and whether the warrant and forward purchase agreement holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant and forward purchase agreement issuance and as of each subsequent quarterly period end date while the warrants forward purchase agreement are outstanding. For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations. The Forward Purchase Agreement entered into on May 31, 2023 (“FSPA” or the “Agreement”) resulted in Meteora holding a put option to sell up to a maximum of 4,200,000 of the Company’s shares. Pursuant to ASC 480, “Distinguishing Liabilities from Equity”, this instrument meets the definition of a liability and accordingly was recognized at fair value. The FSPA resulted in the initial recognition of a forward purchase agreement liability of approximately $2,016,000 and was expensed in our statement of operations. The fair value of this put option was $2,212,335 as of September 30, 2023 and zero at December 31, 2022, assuming the investor will purchase the maximum number of shares. Changes in the estimated fair value of the FSPA are recognized as a non-cash gain or loss on the statements of operations. Class A Common Stock Subject to Possible Redemption The Company accounts for its common stock subject to possible redemption in accordance with the guidance in ASC Topic 480. Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheet. The Company recognizes changes in redemption value at the end of each reporting period and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Such changes are reflected in additional paid-in capital, or in the absence of additional capital, in accumulated deficit. On November 19, 2021, the Company recorded an accretion of $20,121,064. As of September, 2023, the shares of Class A Common Stock, classified as temporary equity in the balance sheet, are reconciled in the following table: ​ ​ ​ ​ ​ Gross proceeds of initial public offering $ 139,711,628 Less: ​ ​ Proceeds allocated to public warrants ​ (5,751,494) Offering costs allocated to Class A Common Stock subject to possible redemption ​ (8,174,948) Plus: ​ ​ Re-measurement on Class A Common Stock subject to possible redemption ​ 20,121,068 Class A Common Stock subject to possible redemption, December 31, 2021 ​ $ 145,906,254 Remeasurement of Class A Common Stock to redemption value ​ ​ 1,105,504 Shares of Class A Common Stock subject to possible redemption at December 31, 2022 ​ $ 147,011,758 Redemption of Class A ordinary shares ​ ​ (113,134,328) Remeasurement of Class A ordinary shares to redemption value ​ ​ 2,436,322 Class A ordinary shares subject to possible redemption value at September 30, 2023 ​ $ 36,313,752 ​ Offering Costs The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A - “Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the Public Offering. Transaction costs for the Company’s IPO amounted to $8,553,410, consisting of $2,875,000 for the underwriting discount, $5,031,250 of deferred underwriting compensation fees, and $647,160 of other offering costs. Offering costs amounted to $8,553,410, of which $8,174,948 were charged to temporary equity upon the completion of the Initial Public Offering and $378,462 were expensed to the statement of operations. Income Taxes The Company accounts for income taxes under ASC 740 Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. The Company may be subject to potential examination by federal and state taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. Net Income (loss) Per Share of Common Stock Net income (loss) per common share is computed by dividing net income by the weighted average number of common stock outstanding for the period. The Company applies the two-class method in calculating earnings per share. Shares of common stock subject to possible redemption at September 30, 2023, which are not currently redeemable and are not redeemable at fair value, have been excluded from the calculation of basic net income (loss) per common share since such shares, if redeemed, only participate in their pro rata share of the Trust Account earnings. The Company has not considered the effect of warrants sold in the Initial Public Offering and the private placement to purchase an aggregate 7,531,250 shares of common stock in the calculation of diluted income (loss) per share, since the exercise of the warrants into shares of common stock is contingent upon the occurrence of future events. As a result, diluted net income (loss) per common share is the same as basic net income (loss) per common share for the period presented. Below is a reconciliation of net income (loss) per common share: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the Three Months Ended ​ For the Nine Months Ended ​ ​ September 30, September 30, ​ September 30, ​ September 30, ​ 2023 2022 2023 2022 Class A common stock subject to possible redemption ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Numerator: Net income (loss) allocable to Class A common stock subject to possible redemption ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Net income (loss) ​ $ (395,997) ​ $ 1,798,216 ​ $ (3,598,813) ​ ​ 4,052,299 Net income (loss) attributable to Class A common stock subject to possible redemption ​ ​ (204,505) ​ ​ 1,438,573 ​ ​ (2,213,599) ​ 3,241,839 Denominator: Weighted average redeemable Class A common stock ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted average shares outstanding, basic and diluted redeemable Class A common stock ​ ​ 3,837,956 ​ ​ 14,375,000 ​ ​ 5,742,884 ​ 14,375,000 Basic and diluted net income (loss) per share, redeemable Class A common share ​ $ (0.05) ​ $ 0.10 ​ $ (0.39) ​ $ 0.23 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Non-Redeemable Class B Common Stock ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Numerator: Net Income (loss) attributable to non-redeemable Class A common stock ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Net income (loss) ​ $ (395,997) ​ $ 1,798,216 ​ $ (3,598,813) ​ ​ 4,052,299 Net Income (loss) attributable to non-redeemable Class A common stock ​ $ (191,492) ​ $ 359,643 ​ $ (1,385,214) ​ ​ 810,460 Denominator: Weighted average non-redeemable Class A common stock ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted average shares outstanding, basic and diluted non-redeemable Class A common stock ​ ​ 3,593,750 ​ ​ 3,593,750 ​ ​ 3,593,750 ​ 3,593,750 Basic and diluted net income (loss) per non-redeemable Class A common share ​ $ (0.05) ​ $ 0.10 ​ $ (0.39) ​ ​ 0.23 ​ Fair value of financial instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal depository insurance coverage of $250,000. At September 30, 2023, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Recent Accounting Standards In August 2020, the FASB issued ASU No. 2020-06, “Debt --Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging --Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. ASU 2020-06 removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, with early adoption permitted. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows. In December 2019, the FASB issued ASU No. 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU 2019-12”), which is intended to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. This guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2021, with early adoption permitted. The adoption of ASU 2019-12, effective January 1, 2022, did not have a material impact on the Company’s financial statements and related footnote disclosures. Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

Public Offering

Public Offering	9 Months Ended
	Sep. 30, 2023
Public Offering
Public Offering	Note 3 — Public Offering Pursuant to the Initial Public Offering, on November 19, 2021, the Company sold 14,375,000 Units, which includes the full exercise by the underwriter of its option to purchase an additional 1,875,000 Units, at a purchase price of $10.00 per Unit. Each Unit consists of one share of the Company’s Class A common stock, $0.0001 par value, and one-half

Private Placement

Private Placement	9 Months Ended
	Sep. 30, 2023
Private Placement
Private Placement	Note 4 — Private Placement Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 7,531,250 Private Placement Warrants at a price of $1.00 per Private Placement Warrant, or $7,531,250 in the aggregate. Each Private Placement Warrant is exercisable to purchase one share of Class A common stock at a price of $11.50 per share. The proceeds from the sale of the Private Placement Warrants were added to the net proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2023
Related Party Transactions
Related Party Transactions	Note 5 — Related Party Transactions Founder Shares In June 2021, the Company issued an aggregate of 3,593,750 shares (the “Founder Shares”) to the Sponsor for an aggregate purchase price of $25,000 in cash. Subsequently, in August 2021, our Sponsor forfeited an aggregate of 718,750 shares for no consideration, thereby resulting in 3,593,750 remaining Founder Shares, included an aggregate of up to 468,750 Founder Shares of Class B common stock subject to forfeiture by the Sponsor to the extent that the underwriter’s over-allotment option was not exercised in full or in part, so that the Sponsor would own, on an as-converted basis, 20% of the Company’s issued and outstanding shares after the Initial Public Offering. As a result of the underwriter’s election to fully exercise its over-allotment option, 468,750 Founder Shares are no longer subject to forfeiture. The initial stockholders have agreed not to transfer, assign or sell any of their Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination or (B) the date on which the Company completes a liquidation, merger, capital stock exchange or similar transaction that results in the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property. Notwithstanding the foregoing, if the last sale price of the Company’s Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Business Combination, the Founder Shares will be released from the lock-up. In February 2023, our Sponsor contributed the Trust Shares and $84,994 (or $0.02 per Remaining Share) to the Company’s trust account in connection with the Meeting. Also in February 2023, the Sponsor converted its remaining 3,393,750 founder shares to shares of Class A Common Stock, subject to the same restrictions as the founder shares. Effective February 17, 2023 the Trust Shares were also converted to Class A Common Stock. Also in February 2023, the Company entered into Non-Redemption Agreements with certain stockholders of the Company holding an aggregate of 3,281,138 shares in exchange for their agreeing not to redeem shares of the Company’s common stock at the Meeting. The Non-Redemption Agreements provide for the allocation of up to 820,284 shares of common stock of the Company held by the Sponsor. The stockholders party to the Non-Redemption Agreements only agreed to refrain from exercising redemption rights in connection with the Meeting and retain their redemption rights in connection with the approval of a Business Combination (or any future amendment to extend the period to complete a Business Combination). In connection with the Second Meeting, our sponsor (or its affiliate) agreed to contribute $0.04 per redeemable share per month into the Trust Account as the Extension Payment. We (as an affiliate of our Sponsor) deposited the Extension Payment into the Trust Account, which was funded through the Working Capital Loan with our Sponsor. Promissory Note and Advances Related Party On June 21, 2021, the Sponsor agreed to loan the Company an aggregate of up to $400,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Note”). The Note was non-interest bearing and was payable on the earlier of June 21, 2022 or the completion of the Initial Public Offering. The outstanding balance under the Note was repaid on November 19, 2021. At September 30, 2023 and September 30, 2022 there were no borrowings outstanding under the Note. In order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor, an affiliate of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of notes may be converted upon consummation of a Business Combination into warrants at a price of $1.00 per warrant. The warrants will be identical to the Private Placement Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. At December 31, 2022, no Working Capital Loans were outstanding. On February 16, 2023, the Sponsor issued a Working Capital Loan to the Company in the form of an unsecured promissory note (the “Sponsor Convertible Note”). Pursuant to the Sponsor Convertible Note, the Company may borrow from the Sponsor, from time to time, up to an aggregate of $1,500,000. Borrowings under the Sponsor Convertible Note will not bear interest. The Note will mature on the earlier to occur of (i) February 19, 2024, or (ii) the consummation of the Business Combination. Up to $1,500,000 of such Sponsor Convertible Note may be converted into warrants of the post-business combination entity, which shall have terms identical to the Private Placement Warrants, at a price of $1.00 per warrant at the option of the Sponsor. The Sponsor Convertible Note contains customary events of default, including those relating to the Company’s failure to repay the principal amount due upon maturity of the Sponsor Convertible Note and certain bankruptcy events. As of September 30, 2023, the Working Capital Loan had a balance of $1,200,000. The conversion option included in the Note is considered an embedded derivative and is remeasured at the end of each reporting period when amounts drawn will be outstanding. The value of the conversion option is de minimis as of September 30, 2023. Administrative Support Agreement The Company entered into an agreement, commencing on November 19, 2021 through the earlier of the Company’s consummation of a Business Combination and its liquidation, to pay the Sponsor a total of $10,000 per month for office space, utilities and secretarial and administrative support. Upon completion of the Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. The Company has paid an aggregate of $90,000 and $90,000, as of September 30, 2023 and September 30, 2022, respectively.

Investment Held in Trust Accoun

Investment Held in Trust Account	9 Months Ended
	Sep. 30, 2023
Investment Held in Trust Account
Investment Held in Trust Account	Note 6 —Investment Held in Trust Account ​ As of September 30, 2023, investment in the Company’s Trust Account consisted of $990 in Cash and Sweep Funds and $36,391,529 in U.S. Treasury Securities that mature on November 16, 2023. The Company classifies its United States Treasury securities as a trading security in accordance with FASB ASC 320 “Investments — Debt and Equity Securities”. The Company classifies its United States Treasury securities as trading securities in accordance with FASB ASC 320 “Investments — Debt and Equity Securities”. The Company considers all investments with original maturities of more than three months but less than one year to be short-term investments.

Commitments & Contingencies

Commitments & Contingencies	9 Months Ended
	Sep. 30, 2023
Commitments & Contingencies
Commitments & Contingencies	Note 7 — Commitments & Contingencies Registration Rights Pursuant to a registration rights agreement entered into on November 17, 2021, the holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of the Working Capital Loans (and any shares of Class A common stock issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) will be entitled to registration rights, requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to our Class A common stock). The holders of the majority of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriters Agreement The underwriter is entitled to a deferred fee of $0.35 per Unit, or $5,031,250 in the aggregate. The deferred fee will become payable to the underwriter from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. ​ On May 3, 2023, the Company and its underwriter amended the terms of its engagement letter such that the underwriter agreed to waive the entirety of its underwriting fee in lieu of a waiver fee of $1,000,000, which is due and payable only upon the consummation of the Company’s business combination with ABM. The fee waiver applies only to a potential business combination with ABM. ​ Forward Purchase Agreement On May 31, 2023, SGII and ABM entered into an OTC Equity Prepaid Forward Transaction agreement (“FSPA”) with Meteora Special Opportunity Fund I, LP, Meteora Capital Partners, LP and Meteora Select Trading Opportunities Master, LP (collectively, “Meteora”). ​ Pursuant to the FSPA, Meteora is expected to purchase up to 4,200,000 shares of SGII Class A common stock (“FSPA Shares”) subject to a cap of 9.9% of outstanding shares on a post-Transaction basis, at a per share price no more than the price per share paid to redeeming SGII public shareholders in connection with the vote to approve the Transactions (the “redemption price”), or up to approximately US $43 million based on the current redemption price, in advance of the consummation of the Transactions. In certain circumstances, including if Meteora purchases less than 4,200,000 FSPA Shares, it will be entitled to receive warrants to purchase shares of SGII common stock in an amount equal to the difference of 4,200,000 and the number of FSPA Shares purchased in the market by Meteora and subject to the FSPA. ​ In connection with its purchase of the FSPA Shares, Meteora will waive its redemption rights in connection with the shareholder vote to approve the Transactions. ​ Following the closing of the Transactions, an amount equal to the number of FSPA Shares multiplied by the redemption price, less 1.00%, will be prepaid to Meteora. The remaining 1.00% (the “Prepayment Shortfall”) will be released to SGII at the closing of the Transactions. The FSPA Shares held by Meteora and subject to the FSPA may be sold into the market by Meteora at any time following the closing of the Transactions. Meteora is entitled to sell into the market FSPA Shares without any payment to SGII until the proceeds from such sales equals the Prepayment Shortfall. SGII may receive up to US $41,580,000 from the termination of all or a portion of the FSPA transaction at $10.00 per terminated FSPA Share, subject to reduction upon any Dilutive Offering Reset. To the extent Meteora elects not to terminate the FSPA transaction prior to the maturity date, SGII will be entitled to receive from Meteora the number of FSPA Shares not so terminated, and Meteora will be entitled to “maturity” consideration, paid in shares or cash, subject to the terms of the FSPA. ​ The FSPA expires at the third anniversary of the closing of the Transactions, subject to acceleration at the Seller’s option upon the volume weighted average price per share being at or below $5.00 per share for any 20 trading days during a 30 consecutive trading day-period and upon any delisting of SGII common stock. ​ The FSPA provides that Meteora is entitled to transfer and/or assign all or a portion of its rights and obligations under the FSPA to one or more third parties of its choosing. Additionally, according to the terms of the FSPA, SGII has agreed to indemnify Meteora against certain losses in connection with the FSPA and to pay certain consideration and fees, including without limitation a quarterly fee, a breakage fee and share consideration equal to 300,000 shares at the redemption price. ​ The Forward Purchase Agreement entered into on May 31, 2023 (“FSPA” or the “Agreement”) resulted in the investor holding a put option on the Company’s shares to sell such shares pursuant to the Agreement, up to the maximum of 4,200,000 shares. Pursuant to ASC 480, “Distinguishing Liabilities from Equity”, this instrument meets the definition of a liability and accordingly was recognized at fair value. The fair value of this put option was $2,212,335 as of September 30, 2023, assuming Meteora will purchase the maximum number of shares. The FSPA resulted in the initial recognition of a FSPA derivative liability of approximately $2,016,000 and was expensed in our statement of operations. Changes in the estimated fair value of the FSPA are recognized as a non-cash gain or loss on the statements of operations.

Stockholders' Equity

Stockholders' Equity	9 Months Ended
	Sep. 30, 2023
Stockholders' Equity
Stockholders' Equity	Note 8 — Stockholders’ Equity Preferred Stock Class A Common Stock (redeemable) Class A Common Stock (non-redeemable) — Class B Common Stock issued outstanding The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the Business Combination on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like. In the case that additional shares of Class A common stock, or equity linked securities, are issued or deemed issued in excess of the amounts offered in the Initial Public Offering and related to the closing of a Business Combination, the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the holders of a majority of the outstanding shares of Class B common stock agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as converted basis, 20% of the sum of the total number of all shares of common stock outstanding upon the completion of the Initial Public Offering plus all shares of Class A common stock and equity linked securities issued or deemed issued in connection with a Business Combination (excluding any shares or equity linked securities issued, or to be issued, to any seller in a Business Combination, and any private placement-equivalent warrants issued to the Sponsor or its affiliates upon conversion of loans made to the Company). The Company may issue additional common stock or preferred stock to complete its Business Combination or under an employee incentive plan after completion of its Business Combination.

Warrant Liability

Warrant Liability	9 Months Ended
	Sep. 30, 2023
Warrant Liability
Warrant Liability	Note 9 – Warrant Liability The Company accounts for the warrants in accordance with the guidance contained in ASC Topic 815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability. Accordingly, the Company will classify each warrant as a liability at its fair value. This liability is subject to re-measurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company’s statement of operations. The Public Warrants will become exercisable 30 days after the consummation of a Business Combination. No Public Warrants will be exercisable for cash unless the Company has an effective and current registration statement covering the common shares issuable upon exercise of the Public Warrants and a current prospectus relating to such common shares. Notwithstanding the foregoing, if a registration statement covering the Class A common shares issuable upon the exercise of the Public Warrants is not effective within 60 days from the consummation of a Business Combination, the holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise the Public Warrants on a cashless basis pursuant to an available exemption from registration under the Securities Act. If an exemption from registration is not available, holders will not be able to exercise their Public Warrants on a cashless basis. The Public Warrants will expire five years from the consummation of a Business Combination or earlier upon redemption or liquidation. The Company may call the Public Warrants for redemption (excluding the Private Placement Warrants), in whole and not in part, at a price of $0.01 per warrant: ● upon not less than 30 days ’ prior written notice of redemption to each Public Warrant holder, ● if, and only if, the last sale price of the Company’s Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30 -trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. In addition, once the warrants become exercisable, the Company may call the warrants for redemption: ● in whole and not in part; ● if the closing price of the shares of Class A common stock for any 20 trading days within a 30 -trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $18.00 per share (as adjusted), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above. The “fair market value” of the Class A common stock for the above purpose shall mean the volume-weighted average price of the Class A common stock during the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.361 Class A common stock per warrant (subject to adjustment). The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the common shares issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and will be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. The exercise price and number of shares of Class A common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend, or recapitalization, reorganization, merger or consolidation. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company’s initial Business Combination on the date of the consummation of such initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price and the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A common shares issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and will be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

Income Tax

Income Tax	9 Months Ended
	Sep. 30, 2023
Income Tax
Income Tax	Note 10 – Income Tax As of September 30, 2023, and December 31, 2022, the Company’s deferred tax asset had a full valuation allowance recorded against it. Our effective tax rate was (34.09%) and (13.46%) for the three and nine months ended September 30, 2023, respectively, and 7.47% and 3.62% for the three and nine months ended September 30, 2022. The effective tax rate differs from the statutory tax rate of 21% for the three and nine months ended September 30, 2023, due to changes in fair of warrant liabilities, fair value of forward purchase agreement liabilities, merger expenses and the valuation allowance on the deferred tax assets.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2023
Fair Value Measurements
Fair Value Measurements	Note 11 — Fair Value Measurements FASB ASC Topic 820 “Fair Value Measurements and Disclosures” (“ASC 820”) defines fair value, the methods used to measure fair value and the expanded disclosures about fair value measurements. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between the buyer and the seller at the measurement date. In determining fair value, the valuation techniques consistent with the market approach, income approach and cost approach shall be used to measure fair value. ASC 820 establishes a fair value hierarchy for inputs, which represent the assumptions used by the buyer and seller in pricing the asset or liability. These inputs are further defined as observable and unobservable inputs. Observable inputs are those that buyer and seller would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs reflect the Company’s assumptions about the inputs that the buyer and seller would use in pricing the asset or liability developed based on the best information available in the circumstances. The fair value hierarchy is categorized into three levels based on the inputs as follows: Level 1 — Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these securities does not entail a significant degree of judgment. Level 2 — Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived principally from or corroborated by market through correlation or other means. Level 3 — Valuations based on inputs that are unobservable and significant to the overall fair value measurement. The fair value of the Company’s certain assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the condensed balance sheet. The fair values of cash and cash equivalents, prepaid assets, accounts payable and accrued expenses, due to related parties are estimated to approximate the carrying values as of September 30, 2023 due to the short maturities of such instruments. The following tables present information about the Company’s assets and liabilities that were measured at fair value on a recurring basis as of September 30, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value. ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, ​ ​ ​ ​ ​ ​ ​ ​ 2023 ​ Level 1 ​ Level 2 ​ Level 3 Assets: ​ ​ ​ ​ U.S. Money Market held in Trust Account ​ $ 990 ​ $ 990 ​ $ — ​ $ — U.S. Treasury Securities held in Trust Account ​ 36,391,529 ​ 36,391,529 ​ — ​ — ​ ​ $ 36,392,519 ​ $ 36,392,519 ​ $ — ​ $ — ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 2022 Level 1 Level 2 Level 3 Assets: ​ ​ ​ ​ U.S. Money Market held in Trust Account ​ $ 923 ​ $ 923 ​ $ — ​ $ — U.S. Treasury Securities held in Trust Account ​ 146,762,512 ​ 146,762,512 ​ — ​ — ​ ​ $ 146,763,435 ​ $ 146,763,435 ​ $ — ​ $ — ​ The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis at September 30, 2023 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value. ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, ​ December 31, ​ November 19, ​ Level 2023 Level 2022 Level 2021 Liabilities: ​ ​ ​ ​ ​ ​ ​ Warrant Liability - Public Warrants ​ 1 ​ $ 395,313 ​ 1 $ 71,875 3 $ 5,751,494 Warrants Liability - Private Placement Warrants ​ 3 ​ ​ 433,424 ​ 3 ​ 90,306 3 ​ 6,194,622 Forward purchase agreement liability ​ 3 ​ ​ 2,212,335 ​ ​ ​ ​ — ​ ​ ​ ​ — Total Derivative Liabilities ​ ​ ​ $ 3,041,072 ​ ​ $ 162,181 ​ $ 11,946,116 ​ The Warrants are accounted for as liabilities in accordance with ASC 815-40 and are presented within the warrant liability on our balance sheet. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of the warrant liabilities in the statement of operations. Warrant Liability - Initial Measurement The Company established the initial fair value for the Public Warrants and Private Placement Warrants on November 19, 2021, the date the Company consummated its Initial Public Offering, using a Monte Carlo simulation model. The Company allocated the proceeds received from (i) the sale of Units (which is inclusive of one Class A common stock and one-half The key inputs into the Monte Carlo simulation model for the Public Warrants and Private Placement Warrants were as follows at initial measurement: ​ ​ ​ ​ ​ ​ ​ November 19, 2021 Input ​ (Initial Measurement) Risk-free interest rate ​ 1.33 % Expected term (years) ​ 5.93 ​ Expected volatility ​ 13.5 % Stock price ​ $ 9.6 ​ ​ As of November 19, 2021, the Public Warrants and Private Placement Warrants were determined to be $0.80 and $0.82 per warrant, respectively, for aggregate values of approximately $5.7 million and $6.2 million, respectively. Warrant Liability - Subsequent Measurement The Warrants are measured at fair value on a recurring basis. The subsequent measurement of the Public Warrants as of September 30, 2023 and December 31, 2022 is classified as Level 1 due to the use of an observable market quote in an active market and the subsequent measurement of the Private Placement Warrants as September 30, 2023 and December 31, 2022 is classified Level 3 due to the use of unobservable inputs. The key inputs into the Monte Carlo simulation model for the Public Warrants and Private Placement Warrants were as follows at the Subsequent Measurements: ​ ​ ​ ​ ​ ​ ​ ​ ​ Input December 31, 2022 September 30, 2023 ​ Risk-free interest rate ​ 4.72 % ​ 5.47 % Expected term (years) ​ 1.04 ​ 0.95 ​ Expected volatility ​ 4.3 % ​ 3.2 % Stock price ​ $ 10.19 ​ $ 10.71 ​ ​ As of December 31, 2022, the Public Warrants and Private Placement Warrants were determined to be approximately $0.02 and $0.02 per warrant for aggregate values of approximately $0.07 million and $0.09 million, respectively. As of September 30, 2023, the Public Warrants and Private Placement Warrants were determined to be $0.06 and $0.06 per warrant for aggregate values of approximately $0.39 million and $0.43 million, respectively. The following table presents the changes in the fair value of warrant liabilities: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Private ​ Warrant ​ ​ Placement ​ Public ​ Liabilities Fair value as of November 19, 2021 ​ $ — ​ $ — ​ $ — Initial measurement on November 19, 2021 ​ ​ 6,194,622 ​ ​ 5,751,494 ​ ​ 11,946,116 Change in valuation inputs or other assumptions ​ (2,373,768) ​ (2,143,369) ​ (4,517,137) Fair value as of December 31, 2021 ​ $ 3,820,854 ​ $ 3,608,125 ​ $ 7,428,979 Change in valuation inputs or other assumptions ​ ​ (1,319,898) ​ ​ (1,242,719) ​ ​ (2,562,617) Fair value as of March 31, 2022 ​ $ 2,500,956 ​ $ 2,365,406 ​ $ 4,866,362 Change in valuation inputs or other assumptions ​ (2,410,650) ​ (2,293,531) ​ (4,704,181) Fair value as of December 31, 2022 ​ $ 90,306 ​ $ 71,875 ​ $ 162,181 Change in valuation inputs or other assumptions ​ ​ 392,240 ​ ​ 360,093 ​ ​ 752,333 Fair value as of March 31, 2023 ​ $ 482,546 ​ $ 431,968 ​ $ 914,514 Change in valuation inputs or other assumptions ​ ​ 196,858 ​ ​ 178,970 ​ ​ 375,828 Fair value as of June 30, 2023 ​ $ 679,404 ​ $ 610,938 ​ $ 1,290,342 Change in valuation inputs or other assumptions ​ ​ (245,980) ​ ​ (215,625) ​ ​ (461,605) Fair value as of September 30, 2023 ​ $ 433,424 ​ $ 395,313 ​ $ 828,737 ​ Level 3 financial liabilities consist of the Private Placement Warrant liability for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation. Changes in fair value measurements categorized within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and recorded as appropriate. Forward Purchase Agreement Liabilities The Company utilizes a Monte Carlo simulation model to value the forward purchase agreement at initiation and at the reporting period, with changes in fair value recognized in the statement of operations. Inherent in the model are assumptions related to share price on valuation date, volatilities, expected life, risk-free rate and probability of business combination. The Company estimates the pre-business combination volatility based on the low historical volatilities exhibited by the Company and SPACs-based and the post-merger volatility is estimated based on the median historical and implied volatilities exhibited by companies operating in the industry of the Company’s expected target. The risk-free interest rate is based on the 3-year and 5-year U.S. Treasury note which is similar to the expected remaining life of the forward purchase agreement. The expected life of the forward purchase agreement is assumed to be equivalent to their remaining contractual term. In order to calculate the fair value of the forward purchase agreement liabilities, the Company utilized the following key inputs: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ May 31, 2023 ​ ​ ​ ​ (Initial measurement) ​ September 30, 2023 Risk-free interest rate ​ ​ 3.95 % ​ 4.0 % Expected term (years) ​ ​ 3.5 ​ ​ 3.25 ​ Stock price ​ 10.35 ​ 10.71 ​ Volatility – pre-business combination ​ 2.6 % 2.4 % Volatility – post-business combination ​ 62.9 % 66.3 % ​ The following table presents the changes in the fair value of the forward purchase agreement liability measured on a recurring basis during the three and nine months ended September 30, 2023: ​ ​ ​ ​ ​ ​ Forward Purchase Agreement Fair value on May 31, 2023 (initial measurement) ​ $ 2,016,000 Change in fair value of forward purchase agreement liabilities ​ (126,000) Fair value as of June 30, 2023 ​ ​ 1,890,000 Change in fair value of forward purchase agreement liabilities ​ ​ 322,335 Fair value as of September 30, 2023 ​ 2,212,335 ​ The changes in the fair value of the forward purchase agreement liabilities for the three and nine months ended September 30, 2023 are $322,335 and $(196,335), respectively. There were no forward purchase agreement liabilities in 2022. There were no transfers between fair value levels during the three and nine months ended September 30, 2023 and 2022.

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2023
Subsequent Events
Subsequent Events	Note 12 — Subsequent Events The Company has evaluated subsequent events through the filing of this Current Report on Form 10-Q and determined that there have been no events that have occurred that would require adjustments to our disclosures in the consolidated financial statements contained herein.

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2023
Significant Accounting Policies
Basis of Presentation	Basis of Presentation The accompanying condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X of the SEC. The results for the three and nine months ended September 30, 2023 are not necessarily indicative of the results to be expected for any future periods. In the opinion of the Company’s management, the accompanying condensed financial statements contain all adjustments necessary for a fair statement of the Company’s financial position as of September 30, 2023, its results of operations for the three- and nine-months ended September 30, 2023 and 2022 and its cash flows for the nine months ended September 30, 2023 and 2022. All such adjustments are of a normal and recurring nature.
Emerging Growth Company Status	Emerging Growth Company Status The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of the financial statement in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Inflation Reduction Act of 2022	Inflation Reduction Act of 2022 Except for franchise and income taxes, the proceeds placed in the trust account in connection with the Company’s initial public offering and any extension payments, as well as any interest earned thereon, shall not be used to pay for potential excise taxes or any other fees or taxes that may be levied on the Company pursuant to any current, pending or future rules or laws, including without limitation any excise tax due under the Inflation Reduction Act of 2022 on any redemptions or stock buybacks by the Company.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2023 or December 31, 2022. The Company had $31,494 of cash as of September 30, 2023 and $292,717 of cash as of December 31, 2022.
Cash and Securities held in Trust Account	Cash and Securities held in Trust Account At September 30, 2023, the assets held in the Trust Account were substantially held in U.S. Treasury Bills. As of September 30, 2023, the Trust Account held $36,391,529 in three-month U.S. Treasury Bills and $990 in cash. As of December 31, 2022, the Trust Account held $147,639,102 in three-month U.S. Treasury Bills and $464 in cash. During the period from January 1, 2023 and September 30, 2023, the Company withdrew $651,323 interest income from the Trust Account to pay its tax obligations and withdrew $40,747 during the period from January 1, 2022 to September 30, 2022. During the three months ended September 30, 2023, the Company withdrew $69,184 interest income from the Trust Account to pay its tax obligations and withdrew $40,747 during the comparable three month period in 2022. The Company classifies its United States Treasury securities as a trading security in accordance with FASB ASC Topic 320 “Investments - Debt and Equity Securities.” Per ASC 320-10-25 Trading securities are bought and held principally for the purpose of selling them in the near term and therefore held for only a short period of time. Trading generally reflects active and frequent buying and selling, and trading securities are generally used with the objective of generating profits on short-term differences in price. However, at acquisition the Company is not precluded from classifying as trading a security it plans to hold for a longer period. Interest income is recognized when earned and included in the “interest income” line item in the statements of operations.
Derivative Financial Instruments	Derivative Financial Instruments
Warrant and Forward Purchase Agreement Liabilities	Warrant and Forward Purchase Agreement Liabilities The Company accounts for warrants and forward purchase agreements as either equity-classified or liability-classified instruments based on an assessment of the warrant’s and forward purchase agreement’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants and forward purchase agreement are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants and forward purchase agreement meet all of the requirements for equity classification under ASC 815, including whether the warrants and forward purchase agreement are indexed to the Company’s own common shares and whether the warrant and forward purchase agreement holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant and forward purchase agreement issuance and as of each subsequent quarterly period end date while the warrants forward purchase agreement are outstanding. For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations. The Forward Purchase Agreement entered into on May 31, 2023 (“FSPA” or the “Agreement”) resulted in Meteora holding a put option to sell up to a maximum of 4,200,000 of the Company’s shares. Pursuant to ASC 480, “Distinguishing Liabilities from Equity”, this instrument meets the definition of a liability and accordingly was recognized at fair value. The FSPA resulted in the initial recognition of a forward purchase agreement liability of approximately $2,016,000 and was expensed in our statement of operations. The fair value of this put option was $2,212,335 as of September 30, 2023 and zero at December 31, 2022, assuming the investor will purchase the maximum number of shares. Changes in the estimated fair value of the FSPA are recognized as a non-cash gain or loss on the statements of operations.
Class A Common Stock Subject to Possible Redemption	Class A Common Stock Subject to Possible Redemption The Company accounts for its common stock subject to possible redemption in accordance with the guidance in ASC Topic 480. Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheet. The Company recognizes changes in redemption value at the end of each reporting period and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Such changes are reflected in additional paid-in capital, or in the absence of additional capital, in accumulated deficit. On November 19, 2021, the Company recorded an accretion of $20,121,064. As of September, 2023, the shares of Class A Common Stock, classified as temporary equity in the balance sheet, are reconciled in the following table: ​ ​ ​ ​ ​ Gross proceeds of initial public offering $ 139,711,628 Less: ​ ​ Proceeds allocated to public warrants ​ (5,751,494) Offering costs allocated to Class A Common Stock subject to possible redemption ​ (8,174,948) Plus: ​ ​ Re-measurement on Class A Common Stock subject to possible redemption ​ 20,121,068 Class A Common Stock subject to possible redemption, December 31, 2021 ​ $ 145,906,254 Remeasurement of Class A Common Stock to redemption value ​ ​ 1,105,504 Shares of Class A Common Stock subject to possible redemption at December 31, 2022 ​ $ 147,011,758 Redemption of Class A ordinary shares ​ ​ (113,134,328) Remeasurement of Class A ordinary shares to redemption value ​ ​ 2,436,322 Class A ordinary shares subject to possible redemption value at September 30, 2023 ​ $ 36,313,752
Offering Costs	Offering Costs The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A - “Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the Public Offering. Transaction costs for the Company’s IPO amounted to $8,553,410, consisting of $2,875,000 for the underwriting discount, $5,031,250 of deferred underwriting compensation fees, and $647,160 of other offering costs. Offering costs amounted to $8,553,410, of which $8,174,948 were charged to temporary equity upon the completion of the Initial Public Offering and $378,462 were expensed to the statement of operations.
Income Taxes	Income Taxes The Company accounts for income taxes under ASC 740 Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. The Company may be subject to potential examination by federal and state taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Net Income (loss) Per Share of Common Stock	Net Income (loss) Per Share of Common Stock Net income (loss) per common share is computed by dividing net income by the weighted average number of common stock outstanding for the period. The Company applies the two-class method in calculating earnings per share. Shares of common stock subject to possible redemption at September 30, 2023, which are not currently redeemable and are not redeemable at fair value, have been excluded from the calculation of basic net income (loss) per common share since such shares, if redeemed, only participate in their pro rata share of the Trust Account earnings. The Company has not considered the effect of warrants sold in the Initial Public Offering and the private placement to purchase an aggregate 7,531,250 shares of common stock in the calculation of diluted income (loss) per share, since the exercise of the warrants into shares of common stock is contingent upon the occurrence of future events. As a result, diluted net income (loss) per common share is the same as basic net income (loss) per common share for the period presented. Below is a reconciliation of net income (loss) per common share: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the Three Months Ended ​ For the Nine Months Ended ​ ​ September 30, September 30, ​ September 30, ​ September 30, ​ 2023 2022 2023 2022 Class A common stock subject to possible redemption ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Numerator: Net income (loss) allocable to Class A common stock subject to possible redemption ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Net income (loss) ​ $ (395,997) ​ $ 1,798,216 ​ $ (3,598,813) ​ ​ 4,052,299 Net income (loss) attributable to Class A common stock subject to possible redemption ​ ​ (204,505) ​ ​ 1,438,573 ​ ​ (2,213,599) ​ 3,241,839 Denominator: Weighted average redeemable Class A common stock ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted average shares outstanding, basic and diluted redeemable Class A common stock ​ ​ 3,837,956 ​ ​ 14,375,000 ​ ​ 5,742,884 ​ 14,375,000 Basic and diluted net income (loss) per share, redeemable Class A common share ​ $ (0.05) ​ $ 0.10 ​ $ (0.39) ​ $ 0.23 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Non-Redeemable Class B Common Stock ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Numerator: Net Income (loss) attributable to non-redeemable Class A common stock ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Net income (loss) ​ $ (395,997) ​ $ 1,798,216 ​ $ (3,598,813) ​ ​ 4,052,299 Net Income (loss) attributable to non-redeemable Class A common stock ​ $ (191,492) ​ $ 359,643 ​ $ (1,385,214) ​ ​ 810,460 Denominator: Weighted average non-redeemable Class A common stock ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted average shares outstanding, basic and diluted non-redeemable Class A common stock ​ ​ 3,593,750 ​ ​ 3,593,750 ​ ​ 3,593,750 ​ 3,593,750 Basic and diluted net income (loss) per non-redeemable Class A common share ​ $ (0.05) ​ $ 0.10 ​ $ (0.39) ​ ​ 0.23
Fair value of financial instruments	Fair value of financial instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal depository insurance coverage of $250,000. At September 30, 2023, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Recent Accounting Standards	Recent Accounting Standards In August 2020, the FASB issued ASU No. 2020-06, “Debt --Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging --Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. ASU 2020-06 removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, with early adoption permitted. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows. In December 2019, the FASB issued ASU No. 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU 2019-12”), which is intended to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. This guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2021, with early adoption permitted. The adoption of ASU 2019-12, effective January 1, 2022, did not have a material impact on the Company’s financial statements and related footnote disclosures. Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

Significant Accounting Polici_3

Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2023
Significant Accounting Policies
Schedule of reconciliation of class A common stock subject to possible redemption	​ ​ ​ ​ ​ Gross proceeds of initial public offering $ 139,711,628 Less: ​ ​ Proceeds allocated to public warrants ​ (5,751,494) Offering costs allocated to Class A Common Stock subject to possible redemption ​ (8,174,948) Plus: ​ ​ Re-measurement on Class A Common Stock subject to possible redemption ​ 20,121,068 Class A Common Stock subject to possible redemption, December 31, 2021 ​ $ 145,906,254 Remeasurement of Class A Common Stock to redemption value ​ ​ 1,105,504 Shares of Class A Common Stock subject to possible redemption at December 31, 2022 ​ $ 147,011,758 Redemption of Class A ordinary shares ​ ​ (113,134,328) Remeasurement of Class A ordinary shares to redemption value ​ ​ 2,436,322 Class A ordinary shares subject to possible redemption value at September 30, 2023 ​ $ 36,313,752
Schedule of reconciliation of net income (loss) per common share	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the Three Months Ended ​ For the Nine Months Ended ​ ​ September 30, September 30, ​ September 30, ​ September 30, ​ 2023 2022 2023 2022 Class A common stock subject to possible redemption ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Numerator: Net income (loss) allocable to Class A common stock subject to possible redemption ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Net income (loss) ​ $ (395,997) ​ $ 1,798,216 ​ $ (3,598,813) ​ ​ 4,052,299 Net income (loss) attributable to Class A common stock subject to possible redemption ​ ​ (204,505) ​ ​ 1,438,573 ​ ​ (2,213,599) ​ 3,241,839 Denominator: Weighted average redeemable Class A common stock ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted average shares outstanding, basic and diluted redeemable Class A common stock ​ ​ 3,837,956 ​ ​ 14,375,000 ​ ​ 5,742,884 ​ 14,375,000 Basic and diluted net income (loss) per share, redeemable Class A common share ​ $ (0.05) ​ $ 0.10 ​ $ (0.39) ​ $ 0.23 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Non-Redeemable Class B Common Stock ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Numerator: Net Income (loss) attributable to non-redeemable Class A common stock ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Net income (loss) ​ $ (395,997) ​ $ 1,798,216 ​ $ (3,598,813) ​ ​ 4,052,299 Net Income (loss) attributable to non-redeemable Class A common stock ​ $ (191,492) ​ $ 359,643 ​ $ (1,385,214) ​ ​ 810,460 Denominator: Weighted average non-redeemable Class A common stock ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted average shares outstanding, basic and diluted non-redeemable Class A common stock ​ ​ 3,593,750 ​ ​ 3,593,750 ​ ​ 3,593,750 ​ 3,593,750 Basic and diluted net income (loss) per non-redeemable Class A common share ​ $ (0.05) ​ $ 0.10 ​ $ (0.39) ​ ​ 0.23

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2023
Fair Value Measurements
Schedule of company's assets that are measured at fair value on a recurring basis	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, ​ ​ ​ ​ ​ ​ ​ ​ 2023 ​ Level 1 ​ Level 2 ​ Level 3 Assets: ​ ​ ​ ​ U.S. Money Market held in Trust Account ​ $ 990 ​ $ 990 ​ $ — ​ $ — U.S. Treasury Securities held in Trust Account ​ 36,391,529 ​ 36,391,529 ​ — ​ — ​ ​ $ 36,392,519 ​ $ 36,392,519 ​ $ — ​ $ — ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 2022 Level 1 Level 2 Level 3 Assets: ​ ​ ​ ​ U.S. Money Market held in Trust Account ​ $ 923 ​ $ 923 ​ $ — ​ $ — U.S. Treasury Securities held in Trust Account ​ 146,762,512 ​ 146,762,512 ​ — ​ — ​ ​ $ 146,763,435 ​ $ 146,763,435 ​ $ — ​ $ —
Schedule of company's liabilities that are measured at fair value on a recurring basis	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, ​ December 31, ​ November 19, ​ Level 2023 Level 2022 Level 2021 Liabilities: ​ ​ ​ ​ ​ ​ ​ Warrant Liability - Public Warrants ​ 1 ​ $ 395,313 ​ 1 $ 71,875 3 $ 5,751,494 Warrants Liability - Private Placement Warrants ​ 3 ​ ​ 433,424 ​ 3 ​ 90,306 3 ​ 6,194,622 Forward purchase agreement liability ​ 3 ​ ​ 2,212,335 ​ ​ ​ ​ — ​ ​ ​ ​ — Total Derivative Liabilities ​ ​ ​ $ 3,041,072 ​ ​ $ 162,181 ​ $ 11,946,116
Schedule of key inputs into the Monte Carlo simulation model for the Public Warrants and Private Placement Warrants	​ ​ ​ ​ ​ ​ ​ November 19, 2021 Input ​ (Initial Measurement) Risk-free interest rate ​ 1.33 % Expected term (years) ​ 5.93 ​ Expected volatility ​ 13.5 % Stock price ​ $ 9.6 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Input December 31, 2022 September 30, 2023 ​ Risk-free interest rate ​ 4.72 % ​ 5.47 % Expected term (years) ​ 1.04 ​ 0.95 ​ Expected volatility ​ 4.3 % ​ 3.2 % Stock price ​ $ 10.19 ​ $ 10.71 ​
Schedule of change in the fair value of the warrant liabilities	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Private ​ Warrant ​ ​ Placement ​ Public ​ Liabilities Fair value as of November 19, 2021 ​ $ — ​ $ — ​ $ — Initial measurement on November 19, 2021 ​ ​ 6,194,622 ​ ​ 5,751,494 ​ ​ 11,946,116 Change in valuation inputs or other assumptions ​ (2,373,768) ​ (2,143,369) ​ (4,517,137) Fair value as of December 31, 2021 ​ $ 3,820,854 ​ $ 3,608,125 ​ $ 7,428,979 Change in valuation inputs or other assumptions ​ ​ (1,319,898) ​ ​ (1,242,719) ​ ​ (2,562,617) Fair value as of March 31, 2022 ​ $ 2,500,956 ​ $ 2,365,406 ​ $ 4,866,362 Change in valuation inputs or other assumptions ​ (2,410,650) ​ (2,293,531) ​ (4,704,181) Fair value as of December 31, 2022 ​ $ 90,306 ​ $ 71,875 ​ $ 162,181 Change in valuation inputs or other assumptions ​ ​ 392,240 ​ ​ 360,093 ​ ​ 752,333 Fair value as of March 31, 2023 ​ $ 482,546 ​ $ 431,968 ​ $ 914,514 Change in valuation inputs or other assumptions ​ ​ 196,858 ​ ​ 178,970 ​ ​ 375,828 Fair value as of June 30, 2023 ​ $ 679,404 ​ $ 610,938 ​ $ 1,290,342 Change in valuation inputs or other assumptions ​ ​ (245,980) ​ ​ (215,625) ​ ​ (461,605) Fair value as of September 30, 2023 ​ $ 433,424 ​ $ 395,313 ​ $ 828,737
Forward Purchase Agreement
Fair Value Measurements
Schedule of key inputs into the Monte Carlo simulation model for the Public Warrants and Private Placement Warrants	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ May 31, 2023 ​ ​ ​ ​ (Initial measurement) ​ September 30, 2023 Risk-free interest rate ​ ​ 3.95 % ​ 4.0 % Expected term (years) ​ ​ 3.5 ​ ​ 3.25 ​ Stock price ​ 10.35 ​ 10.71 ​ Volatility – pre-business combination ​ 2.6 % 2.4 % Volatility – post-business combination ​ 62.9 % 66.3 % ​
Schedule of change in the fair value of the warrant liabilities	​ ​ ​ ​ ​ ​ Forward Purchase Agreement Fair value on May 31, 2023 (initial measurement) ​ $ 2,016,000 Change in fair value of forward purchase agreement liabilities ​ (126,000) Fair value as of June 30, 2023 ​ ​ 1,890,000 Change in fair value of forward purchase agreement liabilities ​ ​ 322,335 Fair value as of September 30, 2023 ​ 2,212,335 ​

Organization and Business Ope_2

Organization and Business Operation (Details)										3 Months Ended	6 Months Ended	9 Months Ended
	Aug. 17, 2023 USD ($)	Aug. 16, 2023 USD ($) item $ / shares	Aug. 14, 2023 USD ($) item $ / shares shares	Feb. 23, 2023 USD ($)	Feb. 16, 2023 shares	Feb. 14, 2023 $ / shares shares	Nov. 25, 2022 USD ($)	Aug. 25, 2022 USD ($)	Nov. 19, 2021 USD ($) $ / shares shares	Sep. 30, 2023 USD ($) $ / shares shares	Jun. 30, 2023 USD ($)	Sep. 30, 2023 USD ($) item $ / shares shares	Dec. 31, 2022 USD ($) shares
Organization and Business Operation
Condition for future business combination number of businesses minimum | item												1
Net proceeds from Initial Public Offering and sale of Private Placement Warrants									$ 145,906,250
Share price | $ / shares									$ 10.15	$ 9.20		$ 9.20
Threshold minimum aggregate fair market value as a percentage of the net assets held in the Trust Account												80%
Threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination												50%
Minimum net tangible assets										$ 5,000,001		$ 5,000,001
Redemption limit percentage without prior consent												20
Unit Price | $ / shares												$ 10.15
Redemption period upon closure												10 days
Maximum allowed dissolution expenses												$ 100,000
Value of shares redeemed										91,056	$ 1,040,287
Cash held outside trust account										31,494		31,494
Working capital deficit										(4,400,000)		(4,400,000)
Cash held outside trust account was available to be withdrawn										284,388		284,388	$ 1,733,316
Cash withdrawn from trust account	$ 69,184			$ 582,139			$ 374,062	$ 40,747
Cash and securities held in Trust Account										$ 36,392,519		$ 36,392,519	$ 147,639,566
Sponsor
Organization and Business Operation
Percentage of common stock converted					46%
Common shares, shares outstanding (in shares) | shares										7,843,498		7,843,498
Aggregate amount remained in Trust account												$ 43,662,709
Class A common stock
Organization and Business Operation
Common shares, shares outstanding (in shares) | shares										0		0	0
Class A common stock | Sponsor
Organization and Business Operation
Number of shares provided for allocation | shares						84,994.96
Issue price per remaining share | $ / shares						$ 0.02
Class B common stock
Organization and Business Operation
Common shares, shares outstanding (in shares) | shares										0		0	3,593,750
Class B common stock | Sponsor
Organization and Business Operation
Number of shares owned by stockholders | shares						3,393,750
Number of shares deposited into trust account | shares						200,000
Number of shares converted | shares					200,000
Voting and Non Redemption agreement
Organization and Business Operation
Number of shares owned by stockholders | shares										3,281,138		3,281,138
Number of shares provided for allocation | shares										820,284		820,284
Number of shares redeemed | shares												10,125,252
Redemption price per share | $ / shares												$ 10.27
Value of shares redeemed												$ 104,000,000
Voting and Non Redemption agreement | Class A common stock
Organization and Business Operation
Ratio to be applied to the stock in the conversion												1
Second Extension Redemption
Organization and Business Operation
Number of one month extension for business combination approved | item			6
Term of extension for business combination			1 month
Number of shares redeemed | shares			861,019
Redemption price per share | $ / shares			$ 10.58
Value of shares redeemed			$ 9,100,000
Common shares, shares outstanding (in shares) | shares			6,982,479
Aggregate amount remained in Trust account			$ 35,800,000
Additional amount remained in Trust account		$ 135,549
Cash and securities held in Trust Account		$ 36,000,000
Number of additional extension payments | item		2
Extension Payments per share | $ / shares		$ 0.015
Private Placement Warrants
Organization and Business Operation
Price of warrant | $ / shares										$ 1		$ 1
Maximum notes convertible into warrants, value										$ 1,500,000		$ 1,500,000
Initial Public Offering
Organization and Business Operation
Number of units sold | shares									14,375,000
Purchase price per unit | $ / shares									$ 10
Proceeds from sale of units, net of offering costs									$ 143,750,000
Initial Public Offering | Sponsor
Organization and Business Operation
Issuance of Class B common stock to initial Stockholders												$ 25,000
Private Placement | Private Placement Warrants
Organization and Business Operation
Number of warrants issued | shares									7,531,250
Price of warrant | $ / shares									$ 1
Proceeds from issuance of private placement warrants									$ 7,531,250
Over-allotment option
Organization and Business Operation
Number of units sold | shares									1,875,000
Purchase price per unit | $ / shares									$ 10

Significant Accounting Polici_4

Significant Accounting Policies (Details) - USD ($)			3 Months Ended		9 Months Ended
	May 31, 2023	Nov. 19, 2021	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Significant Accounting Policies
Cash			$ 31,494		$ 31,494		$ 292,717
Amount withdrawn from trust account to pay tax obligations			69,184	$ 40,747	651,323	$ 40,747
Accretion amount		$ 20,121,064
Transaction costs			8,553,410		8,553,410
Underwriting discount			2,875,000		2,875,000
Deferred underwriting fee payable			5,031,250		5,031,250		5,031,250
Other offering costs			647,160		647,160
Offering costs expensed					378,462
Unrecognized tax benefits							0
Accrued for interest and penalties							0
Cash equivalents			0		0		0
Federal depository insurance coverage			250,000		250,000
Cash and securities held in Trust Account			36,392,519		36,392,519		147,639,566
U.S. Treasury Bills
Significant Accounting Policies
Cash and securities held in Trust Account			36,391,529		36,391,529		147,639,102
U.S. Money Market
Significant Accounting Policies
Cash and securities held in Trust Account			990		990		464
Forward Purchase Agreement
Significant Accounting Policies
Derivative liability							0
Forward Purchase Agreement | Put option
Significant Accounting Policies
Fair value of put option estimated value			2,212,335		2,212,335
Derivative liability	$ 2,016,000
Forward Purchase Agreement | Maximum [Member] | Put option
Significant Accounting Policies
Repurchase of stock	4,200,000
Fair value of put option estimated value			$ 2,212,335		2,212,335		$ 0
Derivative liability	$ 2,016,000
Initial Public Offering
Significant Accounting Policies
Offering costs charged to temporary equity					$ 8,174,948

Significant Accounting Polici_5

Significant Accounting Policies - Class A ordinary shares subject to possible redemption (Details) - USD ($)		9 Months Ended	12 Months Ended
	Nov. 19, 2021	Sep. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Significant Accounting Policies
Re-measurement on Class A ordinary shares subject to possible redemption	$ 20,121,064
Class A common stock subject to possible redemption
Significant Accounting Policies
Gross proceeds of initial public offering				$ 139,711,628
Proceeds allocated to public warrants				(5,751,494)
Offering costs allocated to Class A Common Stock subject to possible redemption				(8,174,948)
Balance at the beginning		$ 147,011,758	$ 145,906,254
Redemption of Class A ordinary shares		(113,134,328)
Re-measurement on Class A ordinary shares subject to possible redemption		2,436,322	1,105,504	20,121,068
Balance at the end		$ 36,313,752	$ 147,011,758	$ 145,906,254

Significant Accounting Polici_6

Significant Accounting Policies - Net Income Per Share of Common Stock (Details) - USD ($)	3 Months Ended		6 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Significant Accounting Policies
Antidilutive securities excluded from computation of earnings per share					7,531,250
Class A common stock subject to possible redemption
Net income (loss)	$ (395,997)	$ 1,798,216	$ (3,202,816)	$ 2,254,083	$ (3,598,813)	$ 4,052,299
Numerator: Net Income
Net income (loss)	(395,997)	1,798,216			(3,598,813)	4,052,299
Class A common stock subject to possible redemption
Numerator: Net Income
Net income (loss) attributable to Class A common stock subject to possible redemption	$ (204,505)	$ 1,438,573			$ (2,213,599)	$ 3,241,839
Denominator: Weighted average common stock
Weighted average shares outstanding, basic	3,837,956	14,375,000			5,742,884	14,375,000
Weighted average shares outstanding, diluted	3,837,956	14,375,000			5,742,884	14,375,000
Basic net income (loss) per common share	$ (0.05)	$ 0.10			$ (0.39)	$ 0.23
Diluted net income (loss) per common share	$ (0.05)	$ 0.10			$ (0.39)	$ 0.23
Non Redeemable Class B Common Stock
Numerator: Net Income
Net Income (loss) attributable to non-redeemable Class A and Class B common stock	$ (191,492)	$ 359,643			$ (1,385,214)	$ 810,460
Denominator: Weighted average common stock
Weighted average shares outstanding, basic	3,593,750	3,593,750			3,593,750	3,593,750
Weighted average shares outstanding, diluted	3,593,750	3,593,750			3,593,750	3,593,750
Basic net income (loss) per common share	$ (0.05)	$ 0.10			$ (0.39)	$ 0.23
Diluted net income (loss) per common share	$ (0.05)	$ 0.10			$ (0.39)	$ 0.23

Public Offering (Details)

Public Offering (Details) - $ / shares		9 Months Ended
	Nov. 19, 2021	Sep. 30, 2023	Dec. 31, 2022
Public Offering
Number of shares in a unit		1
Number of warrants in a unit		0.5
Class A common stock
Public Offering
Common stock, par value (in dollars per share)		$ 0.0001	$ 0.0001
Initial Public Offering
Public Offering
Number of units sold	14,375,000
Purchase price per unit	$ 10
Initial Public Offering | Public Warrants
Public Offering
Number of warrants in a unit	0.5
Initial Public Offering | Class A common stock
Public Offering
Number of shares in a unit	1
Common stock, par value (in dollars per share)	$ 0.0001
Initial Public Offering | Class A common stock | Public Warrants
Public Offering
Number of shares issuable per warrant	1
Exercise price of warrants	$ 11.50
Over-allotment option
Public Offering
Number of units sold	1,875,000
Purchase price per unit	$ 10

Private Placement (Details)

Private Placement (Details) - Private Placement Warrants - USD ($)	Nov. 19, 2021	Sep. 30, 2023
Private Placement
Price of warrants		$ 1
Private Placement
Private Placement
Number of warrants to purchase shares issued	7,531,250
Price of warrants	$ 1
Proceeds from issuance of private placement warrants	$ 7,531,250
Number of shares issuable per warrant	1
Exercise price of warrant	$ 11.50

Related Party Transactions - Fo

Related Party Transactions - Founder Shares (Details) - USD ($)		1 Months Ended			9 Months Ended
	Feb. 14, 2023	Feb. 28, 2023	Aug. 31, 2021	Jun. 30, 2021	Sep. 30, 2023	Dec. 31, 2022
Voting and Non Redemption agreement
Related Party Transactions
Aggregate number of shares owned					3,281,138
Number of shares provided for allocation					820,284
Class B common stock
Related Party Transactions
Common stock, shares outstanding (in shares)					0	3,593,750
Class A common stock
Related Party Transactions
Common stock, shares outstanding (in shares)					0	0
Sponsor
Related Party Transactions
Common stock, shares outstanding (in shares)					7,843,498
Sponsor | Class B common stock
Related Party Transactions
Aggregate number of shares owned	3,393,750
Sponsor | Class A common stock
Related Party Transactions
Number of shares provided for allocation	84,994.96
Issue price per remaining share	$ 0.02
Founder Shares | Related party | Voting and Non Redemption agreement
Related Party Transactions
Aggregate number of shares owned		3,281,138
Founder Shares | Sponsor
Related Party Transactions
Shares forfeited			718,750
Percentage of issued and outstanding shares after the initial public offering collectively held by initial stockholders			20%
Shares no longer subject to forfeiture			468,750
Restrictions on transfer period of time after business combination completion					1 year
Sponsor Contribution to Company's Trust Account		$ 84,994
Issue price per remaining share		$ 0.02
Contribution price per share into trust account		$ 0.04
Common stock, shares outstanding (in shares)			3,593,750
Founder Shares | Sponsor | Voting and Non Redemption agreement
Related Party Transactions
Number of shares provided for allocation		820,284
Founder Shares | Sponsor | Class B common stock
Related Party Transactions
Issuance of common stock to Sponsor (in shares)				3,593,750
Issuance of common stock to sponsor				$ 25,000
Shares subject to forfeiture			468,750
Founder Shares | Sponsor | Class A common stock
Related Party Transactions
Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share)					$ 12
Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination					20 days
Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination					30 days
Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences					150 days
Number of shares converted		3,393,750

Related Party Transactions Prom

Related Party Transactions Promissory Note and Advances (Details) - USD ($)			9 Months Ended
	Feb. 16, 2023	Nov. 19, 2021	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Jun. 21, 2021
Related Party Transactions
Outstanding balance			$ 1,200,000
Working Capital Loan Outstanding Balance			1,200,000
Promissory Note | Sponsor
Related Party Transactions
Outstanding balance			$ 0	$ 0
Promissory Note | Maximum | Sponsor
Related Party Transactions
Loan conversion agreement warrant						$ 400,000
Promissory Note | Working capital loans warrant | Related party
Related Party Transactions
Price of warrant			$ 1
Administrative Support Agreement | Sponsor
Related Party Transactions
Administrative Fees Payable Per Month		$ 10,000
Administrative Fees Expense			$ 90,000	$ 90,000
Working Capital Loans | Sponsor
Related Party Transactions
Exercise price of warrants	$ 1
Working Capital Loan Outstanding Balance			1,200,000
Working Capital Loans | Maximum
Related Party Transactions
Conversion amount	$ 1,500,000
Working Capital Loans | Maximum | Related party
Related Party Transactions
Maximum borrowing capacity of related party promissory note			1,500,000
Working Capital Loans | Maximum | Sponsor
Related Party Transactions
Maximum borrowing capacity of related party promissory note			$ 1,500,000
Working Capital Loans | Working capital loans warrant | Related party
Related Party Transactions
Outstanding balance					$ 0

Investment Held in Trust Acco_2

Investment Held in Trust Account (Details) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Investment Held in Trust Account
Assets held in Trust Account	$ 36,392,519	$ 147,639,566
U.S. Money Market
Investment Held in Trust Account
Assets held in Trust Account	990	464
U.S. Treasury Securities held in Trust Account
Investment Held in Trust Account
Assets held in Trust Account	$ 36,391,529	$ 147,639,102

Commitments & Contingencies (De

Commitments & Contingencies (Details)				3 Months Ended	6 Months Ended
	May 31, 2023 USD ($) D $ / shares shares	May 03, 2023 USD ($)	Nov. 19, 2021 USD ($)	Sep. 30, 2023 USD ($) item $ / shares	Jun. 30, 2023 USD ($)	Dec. 31, 2022 USD ($)
Commitments & Contingencies
Maximum number of demands for registration of securities | item				3
Deferred fee per unit | $ / shares				$ 0.35
Deferred underwriting fee payable				$ 5,031,250		$ 5,031,250
Amount of underwriting fee agreed to waive		$ 1,000,000
Value of shares redeemed				91,056	$ 1,040,287
Proceeds from sale of stock			$ 145,906,250
Forward Purchase Agreement
Commitments & Contingencies
Derivative liability						0
Forward Purchase Agreement | Put option
Commitments & Contingencies
Fair value of put option estimated value				2,212,335
Derivative liability	$ 2,016,000
Forward Purchase Agreement | Maximum | Put option
Commitments & Contingencies
Repurchase of stock | shares	4,200,000
Fair value of put option estimated value				$ 2,212,335		$ 0
Derivative liability	$ 2,016,000
OTC Equity Prepaid Forward Transaction agreement | Class A common stock
Commitments & Contingencies
Shares issued | shares	4,200,000
Percentage of share outstanding	9.90%
Value of shares redeemed	$ 43,000,000
Redemption price percentage	1%
Sale of stock, price per share | $ / shares	$ 10
Weighted average price per share from sale of stock transaction | $ / shares	$ 5
Sale of stock transaction trading days during period | D	20
Sale of stock transaction consecutive trading days during period | D	30
Share consideration | shares	300,000
OTC Equity Prepaid Forward Transaction agreement | Class A common stock | Maximum
Commitments & Contingencies
Shares issued | shares	4,200,000
Proceeds from sale of stock	$ 41,580,000

Stockholders' Equity - Preferre

Stockholders' Equity - Preferred Stock (Details) - $ / shares	Sep. 30, 2023	Dec. 31, 2022
Stockholders' Equity
Preferred stock, shares authorized (in shares)	1,000,000	1,000,000
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0

Stockholders' Equity - Common S

Stockholders' Equity - Common Stock (Details)		9 Months Ended
	Feb. 16, 2023 shares	Sep. 30, 2023 Vote $ / shares shares	Dec. 31, 2022 $ / shares shares
Stockholders' Equity
Number of Class B common shares converted to shares of Class A Common Stock	3,593,750
Class A common stock
Stockholders' Equity
Common stock, shares authorized (in shares)		100,000,000	100,000,000
Common stock, par value (in dollars per share) | $ / shares		$ 0.0001	$ 0.0001
Common stock, votes per share | Vote		1
Common stock, shares issued (in shares)		0	0
Common stock, shares outstanding (in shares)		0	0
Class A common stock subject to possible redemption
Stockholders' Equity
Class A common stock subject to possible redemption, outstanding (in shares)		3,388,729	14,375,000
Class A common stock non-redeemable
Stockholders' Equity
Common stock, shares authorized (in shares)		100,000,000	100,000,000
Common stock, par value (in dollars per share) | $ / shares		$ 0.0001	$ 0.0001
Common stock, shares issued (in shares)		3,593,750	0
Common stock, shares outstanding (in shares)		3,593,750	0
Class B common stock
Stockholders' Equity
Common stock, shares authorized (in shares)		10,000,000	10,000,000
Common stock, par value (in dollars per share) | $ / shares		$ 0.0001	$ 0.0001
Common stock, votes per share | Vote		1
Common stock, shares issued (in shares)		0	3,593,750
Common stock, shares outstanding (in shares)		0	3,593,750
Ratio to be applied to the stock in the conversion		20

Warrant Liability (Details)

Warrant Liability (Details)	9 Months Ended
	Sep. 30, 2023 D $ / shares shares	Nov. 19, 2021 $ / shares
Warrant Liability
Public Warrants exercisable term from the closing of the business combination	30 days
Maximum threshold period for registration statement to become effective after business combination	60 days
Warrants expiration term	5 years
Redemption price per public warrant (in dollars per share)	$ 0.01
Minimum threshold written notice period for redemption of public warrants	30 days
Stock price trigger for redemption of public warrants (in dollars per share)	$ 18
Threshold trading days for redemption of public warrants	20 days
Threshold consecutive trading days for redemption of public warrants	30 days
Number of trading days on which fair market value of shares is reported | D	10
Shares issuable per warrant | shares	0.361
Share price	$ 9.20	$ 10.15
Percentage of gross proceeds on total equity proceeds	60%
Threshold period for filling registration statement after business combination	20 days
Adjustment of exercise price of warrants based on market value and newly issued price (as a percent)	115%
Adjustment of redemption price of stock based on market value and newly issued price 1 (as a percent)	180%
Threshold business days before sending notice of redemption to warrant holders	30 days

Income Tax - (Details)

Income Tax - (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Tax
Statutory federal income tax rate	34.09%	7.47%	13.46%	3.62%
Effective tax rate	21%		21%

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of company's assets that are measured at fair value on a recurring basis (Detail) - Recurring - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Assets:
Assets	$ 36,392,519	$ 146,763,435
Level 1
Assets:
Assets	36,392,519	146,763,435
U.S. Money Market held in Trust Account
Assets:
Assets	990	923
U.S. Money Market held in Trust Account | Level 1
Assets:
Assets	990	923
U.S. Treasury Securities held in Trust Account
Assets:
Assets	36,391,529	146,762,512
U.S. Treasury Securities held in Trust Account | Level 1
Assets:
Assets	$ 36,391,529	$ 146,762,512

Fair Value Measurements - Sch_2

Fair Value Measurements - Schedule of company's liabilities that are measured at fair value on a recurring basis (Details) - USD ($)	Sep. 30, 2023	Dec. 31, 2022	Nov. 19, 2021
Liabilities:
Forward purchase agreement liability	$ 2,212,335
Recurring
Liabilities:
Total Derivative Liabilities	3,041,072	$ 162,181	$ 11,946,116
Level 1 | Recurring | Public Warrants
Liabilities:
Warrant Liability	395,313	71,875
Level 3 | Recurring
Liabilities:
Forward purchase agreement liability	2,212,335
Level 3 | Recurring | Public Warrants
Liabilities:
Warrant Liability			5,751,494
Level 3 | Recurring | Private Placement Warrants
Liabilities:
Warrant Liability	$ 433,424	$ 90,306	$ 6,194,622

Fair Value Measurements - Key i

Fair Value Measurements - Key inputs into the Monte Carlo simulation model for the Public Warrants and Private Placement Warrants (Details)	9 Months Ended
	Sep. 30, 2023 $ / shares Y shares	Dec. 31, 2022 Y $ / shares	Nov. 19, 2021 Y $ / shares
Fair Value Measurements
Number of shares in a unit	1
Number of warrants in a unit	0.5
Risk-free interest rate | Monte Carlo simulation model
Fair Value Measurements
Derivative liability, measurement input	0.0547	0.0472	0.0133
Expected term (years) | Monte Carlo simulation model
Fair Value Measurements
Derivative liability, measurement input | Y	0.95	1.04	5.93
Expected volatility | Monte Carlo simulation model
Fair Value Measurements
Derivative liability, measurement input	0.032	0.043	0.135
Stock price | Monte Carlo simulation model
Fair Value Measurements
Derivative liability, measurement input | $ / shares	10.71	10.19	9.6

Fair Value Measurements - Chang

Fair Value Measurements - Change in the Fair Value of the Warrant Liabilities (Details) - USD ($)		1 Months Ended	3 Months Ended					9 Months Ended
	Nov. 19, 2021	Dec. 31, 2021	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Mar. 31, 2022	Sep. 30, 2023	Dec. 31, 2022	Sep. 30, 2022
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Fair value - beginning balance			$ 1,290,342	$ 914,514	$ 162,181		$ 7,428,979	$ 162,181	$ 4,866,362	$ 7,428,979
Initial measurement on November 19, 2021	$ 11,946,116
Change in valuation inputs or other assumptions		$ (4,517,137)	(461,605)	375,828	752,333	$ (1,636,842)	(2,562,617)	666,556	(4,704,181)	(5,093,141)
Fair value - ending balance		7,428,979	828,737	1,290,342	914,514		4,866,362	828,737	162,181
Public Warrants
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Fair value - beginning balance			610,938	431,968	71,875		3,608,125	71,875	2,365,406	3,608,125
Initial measurement on November 19, 2021	5,751,494
Change in valuation inputs or other assumptions		(2,143,369)	(215,625)	178,970	360,093		(1,242,719)		(2,293,531)
Fair value - ending balance		3,608,125	395,313	610,938	431,968		2,365,406	395,313	71,875
Private Placement Warrants
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Fair value - beginning balance			679,404	482,546	90,306		3,820,854	90,306	2,500,956	$ 3,820,854
Initial measurement on November 19, 2021	$ 6,194,622
Change in valuation inputs or other assumptions		(2,373,768)	(245,980)	196,858	392,240		(1,319,898)		(2,410,650)
Fair value - ending balance		$ 3,820,854	$ 433,424	$ 679,404	$ 482,546		$ 2,500,956	$ 433,424	$ 90,306

Fair Value Measurements - Forwa

Fair Value Measurements - Forward purchase agreement derivative liabilities (Details) - Forward Purchase Agreement	Sep. 30, 2023 Y $ / shares	May 31, 2023 Y $ / shares
Risk-free interest rate
Fair Value Measurements
Derivative liability, measurement input	0.040	0.0395
Expected term (years)
Fair Value Measurements
Derivative liability, measurement input | Y	3.25	3.5
Stock price
Fair Value Measurements
Derivative liability, measurement input | $ / shares	10.71	10.35
Volatility - pre-business combination
Fair Value Measurements
Derivative liability, measurement input	0.024	0.026
Volatility - post-business combination
Fair Value Measurements
Derivative liability, measurement input	0.663	0.629

Fair Value Measurements - Fair

Fair Value Measurements - Fair value of forward purchase agreement derivative liability (Details) - USD ($)	1 Months Ended	3 Months Ended	9 Months Ended
	Jun. 30, 2023	Sep. 30, 2023	Sep. 30, 2023
Fair Value Measurements
Fair value - beginning balance		$ 1,290,342	$ 162,181
Change in fair value of forward purchase agreement liability		322,335	196,335
Fair value - ending balance	$ 1,290,342	828,737	828,737
Forward Purchase Agreement
Fair Value Measurements
Change in fair value of forward purchase agreement liability		(322,335)	196,335
Forward Purchase Agreement | Recurring
Fair Value Measurements
Fair value - beginning balance	2,016,000	1,890,000
Change in fair value of forward purchase agreement liability	(126,000)	322,335
Fair value - ending balance	$ 1,890,000	$ 2,212,335	$ 2,212,335

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Details) - USD ($)		3 Months Ended		9 Months Ended
	Nov. 19, 2021	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022	Dec. 31, 2021
Fair Value Measurements
Initial fair value of warrants	$ 11,946,116
Fair value of warrants		$ 828,737		$ 828,737		$ 1,290,342	$ 914,514	$ 162,181	$ 4,866,362	$ 7,428,979
Change in fair value of forward purchase agreement liability		(322,335)		(196,335)
Transfers between fair value levels		0	$ 0	0	$ 0
Forward Purchase Agreement
Fair Value Measurements
Change in fair value of forward purchase agreement liability		$ 322,335		$ (196,335)
Derivative liability								$ 0
Public Warrants
Fair Value Measurements
Exercise price of warrants	$ 0.80	$ 0.06		$ 0.06				$ 0.02
Initial fair value of warrants	$ 5,700,000
Fair value of warrants		$ 390,000		$ 390,000				$ 70,000
Private Placement Warrants
Fair Value Measurements
Exercise price of warrants	$ 0.82	$ 0.06		$ 0.06				$ 0.02
Initial fair value of warrants	$ 6,200,000
Fair value of warrants		$ 430,000		$ 430,000				$ 90,000